Literature DB >> 18718504

Neuronal RA175/SynCAM1 isoforms are processed by tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM17-like proteases.

Yuko Tanabe1, Tadashi Kasahara, Takashi Momoi, Eriko Fujita.   

Abstract

RA175/SynCAM1, a member of immunoglobulin superfamily 4 (Igsf4; recently named Cadm1), is a cell adhesion molecule involved in the formation of a functional synapse. Little is known about the modulation of RA175/SynCAM1-mediated synaptic formation and plasticity. Neurons express two major isoforms containing exons 7-8a-8b-9 and exons 7-8b-9. We found that these isoforms were processed within an 11-amino acid sequence, encoded by exon 8b, near the transmembrane domain. TNF-alpha protease inhibitor-1 (TAPI-1) blocked the processing of RA175/SynCAM1 (exons 7-8a-8b-9). Furthermore, TAPI-1 increased the number of synaptophysin and RA175/SynCAM1 colocalization on the dendrites of neurons. Non-cleaved RA175/SynCAM1 was located at the synapse and membrane-bound, cleaved fragments were detected at the non-synaptic region of dendrites. These results suggest that tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM17-like proteases play a role in synaptic formation to generate specific neuronal connections by processing the excess amount of RA175/SynCAM1 located in the non-synaptic region.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718504     DOI: 10.1016/j.neulet.2008.08.023

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Interaction of nectin-like molecule 2 with integrin alpha6beta4 and inhibition of disassembly of integrin alpha6beta4 from hemidesmosomes.

Authors:  Kiyohito Mizutani; Satoshi Kawano; Akihiro Minami; Masazumi Waseda; Wataru Ikeda; Yoshimi Takai
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 2.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

3.  Axoglial Adhesion by Cadm4 Regulates CNS Myelination.

Authors:  Nimrod Elazar; Anya Vainshtein; Neev Golan; Bharath Vijayaragavan; Nicole Schaeren-Wiemers; Yael Eshed-Eisenbach; Elior Peles
Journal:  Neuron       Date:  2018-12-11       Impact factor: 17.173

4.  Processing of the synaptic cell adhesion molecule neurexin-3beta by Alzheimer disease alpha- and gamma-secretases.

Authors:  Nathalie Bot; Claude Schweizer; Saoussen Ben Halima; Patrick C Fraering
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

Review 5.  Activity-dependent proteolytic cleavage of cell adhesion molecules regulates excitatory synaptic development and function.

Authors:  Sivapratha Nagappan-Chettiar; Erin M Johnson-Venkatesh; Hisashi Umemori
Journal:  Neurosci Res       Date:  2016-12-10       Impact factor: 3.304

6.  CADM1 isoforms differentially regulate human mast cell survival and homotypic adhesion.

Authors:  Elena P Moiseeva; Mark L Leyland; Peter Bradding
Journal:  Cell Mol Life Sci       Date:  2012-03-22       Impact factor: 9.261

7.  CADM1 is a key receptor mediating human mast cell adhesion to human lung fibroblasts and airway smooth muscle cells.

Authors:  Elena P Moiseeva; Katy M Roach; Mark L Leyland; Peter Bradding
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

Review 8.  Proteolytic remodeling of the synaptic cell adhesion molecules (CAMs) by metzincins in synaptic plasticity.

Authors:  Malgorzata Bajor; Leszek Kaczmarek
Journal:  Neurochem Res       Date:  2012-11-04       Impact factor: 3.996

9.  CADM1 is expressed as multiple alternatively spliced functional and dysfunctional isoforms in human mast cells.

Authors:  Elena P Moiseeva; Mark L Leyland; Peter Bradding
Journal:  Mol Immunol       Date:  2012-10-11       Impact factor: 4.407

10.  The intracellular domain of cell adhesion molecule 1 is present in emphysematous lungs and induces lung epithelial cell apoptosis.

Authors:  Man Hagiyama; Azusa Yoneshige; Takao Inoue; Yasufumi Sato; Takahiro Mimae; Morihito Okada; Akihiko Ito
Journal:  J Biomed Sci       Date:  2015-08-11       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.